CDH1 and neoplasm: miR-23a contributes to tumor progression through the suppression of tumor suppressor genes, including PTEN and E-cadherin, and also participates in the control of apoptosis and in the development of drug resistance, thereby reducing the sensitivity to chemotherapy [7,11,12].